Search research articles
Contact Us
Filters
Showing results (1-10 of 3) with videos related to
Page
of 1
Sort By:
Cancer Journal (Sudbury, Mass.)
|
April 9, 2008
Chemotherapy-induced nausea and vomiting
Lisa Lohr
Plos One
|
October 22, 2016
Characterization of Pharmacologic and Pharmacokinetic Properties of CCX168, a Potent and Selective Orally Administered Complement 5a Receptor Inhibitor, Based on Preclinical Evaluation and Randomized Phase 1 Clinical Study
Pirow Bekker, Daniel Dairaghi, Lisa Seitz, et al.
Plos One
|
January 5, 2019
Correction: Characterization of Pharmacologic and Pharmacokinetic Properties of CCX168, a Potent and Selective Orally Administered Complement 5a Receptor Inhibitor, Based on Preclinical Evaluation and Randomized Phase 1 Clinical Study
Pirow Bekker, Daniel Dairaghi, Lisa Seitz, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 3) with videos related to
Sort By:
Page
of 1
Cancer Journal (Sudbury, Mass.)
|
April 9, 2008
Chemotherapy-induced nausea and vomiting
Lisa Lohr
Plos One
|
October 22, 2016
Characterization of Pharmacologic and Pharmacokinetic Properties of CCX168, a Potent and Selective Orally Administered Complement 5a Receptor Inhibitor, Based on Preclinical Evaluation and Randomized Phase 1 Clinical Study
Pirow Bekker, Daniel Dairaghi, Lisa Seitz, et al.
Plos One
|
January 5, 2019
Correction: Characterization of Pharmacologic and Pharmacokinetic Properties of CCX168, a Potent and Selective Orally Administered Complement 5a Receptor Inhibitor, Based on Preclinical Evaluation and Randomized Phase 1 Clinical Study
Pirow Bekker, Daniel Dairaghi, Lisa Seitz, et al.
Page
of 1